About
Soft-tissue regeneration
Areas of Focus
Categories
Wound HealingNew Zealand
Team (5)
Barnaby C
Chief Scientific Officer
Aroa Biosurgery
executive
Brian Ward
Founder and Chief Executive Officer
Aroa Biosurgery
executivefounder
James Agnew
Chief Financial Officer and Joint Company Secretary
Aroa Biosurgery
executive
Rod Stanley
Chief Operating Officer
Aroa Biosurgery
executive
Yasmin Winchester
Chief of Technical Operations
Aroa Biosurgery
team_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
964
By Phase
NA: 2
By Status
RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06035536Lead Sponsor
Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers
NARecruiting
120 participants
Started: Jun 8, 2023 · Completed: Dec 27, 2025
NCT05243966Lead Sponsor
Myriad™ Augmented Soft Tissue Reconstruction Registry
N/ARecruiting
800 participants
Started: Jan 10, 2022 · Completed: Jan 31, 2029
NCT06035523Lead Sponsor
Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™
NACompleted
44 participants
Started: Dec 29, 2021 · Completed: Aug 30, 2025
Locations (1)
Headquarters
Auckland, New Zealand
Map
Loading map...